Trius Therapeutics, Inc. (TSRX)

[LongRun8]

Happy for us TSRX longs, but a little disappointed in the price of $13.50. I thought tedizolid would be able to approach $1 billion market share, so had they not sold out so early, I think we could have made much more. Basically, by selling before FDA approval and any sales, I think they sold themselves short. What if the drug somehow (although very unlikely) doesn't get approved by FDA? Is the acquisition cancelled? I don't know if we have those specifics yet, as the PR is vague. Maybe TSRX is selling for $13.50 to lock in profits, hedging their bets in case FDA doesn't approve. But with their pipeline, $13.50 seems really low.

So I assume stock is halted now; so when should we expect the cash payment for our shares?